{"transactions":[{"id":4281080,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2017-06-15T17:14:10.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that he beneficially owned an aggregate of 433,786 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":250000,"derivative":{"exercise_price":3.5,"exercise_date":"2019-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-17-000123","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225217000123/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281079,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2017-06-15T17:14:10.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that he beneficially owned an aggregate of 433,786 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":166667,"derivative":{"exercise_price":3.5,"exercise_date":"2018-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-17-000123","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225217000123/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4281078,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2017-06-15T17:14:10.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 23, 2016 the Reporting Person filed a Form 4 that inadvertently reported that he beneficially owned an aggregate of 433,786 derivative securities. This amended Form 4 is being filed to correct the number of derivative securities owned by the Reporting Person following the reported transaction."}],"balance_after":83333,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001662252-17-000123","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225217000123/form4a.xml","form_type":"4/A","original_submission_date":"2016-12-23"}},{"id":4512554,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2016-12-23T14:20:40.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."}],"balance_after":443786,"derivative":{"exercise_price":3.5,"exercise_date":"2019-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-16-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225216000305/form4.xml","form_type":"4"}},{"id":4512553,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2016-12-23T14:20:40.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."}],"balance_after":360453,"derivative":{"exercise_price":3.5,"exercise_date":"2018-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001662252-16-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225216000305/form4.xml","form_type":"4"}},{"id":4512552,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":175197,"kind":"person","name":"Maguire Michael Scott","position":1,"cik":"0001690490","reported_name":"Maguire Michael Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2016-12-23T14:20:40.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 250,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option has a ten-year life and vests one-third upon the first anniversary of the grant date, one-third upon the second anniversary of the grant date and one-third on the third anniversary of the grant date."}],"balance_after":277120,"derivative":{"exercise_price":3.5,"exercise_date":"2017-12-20","expiration_date":"2026-12-20","underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001662252-16-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690490/000166225216000305/form4.xml","form_type":"4"}}]}